|Articles|June 1, 2016
- Pharmaceutical Executive-06-01-2016
- Volume 36
- Issue 6
Pharmaceutical Executive, June 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pharm Exec's Top 50 Companies 2016almost 10 years ago
Diversity and Inclusion: A Pharma 50 Perspectivealmost 10 years ago
Market Access in Europe: Building Health Equity Through Better Outcomesalmost 10 years ago
Design that Deliversalmost 10 years ago
A Digital Prescription for the Pharma Industryalmost 10 years ago
Science Meets Art: Mapping the Topography of MSalmost 10 years ago
Pharma and Biotech Financial Outlook: Hazyalmost 10 years ago
Promises and Pitfalls in Calculating Drug Valuealmost 10 years ago
Europe’s ‘Radical’ Regulators Drawn Further into Pricing Debatealmost 10 years ago
Country Report: ItalyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5